Literature DB >> 9952427

Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain.

T Cartmell1, T Southgate, G S Rees, M G Castro, P R Lowenstein, G N Luheshi.   

Abstract

Adenovirus-mediated gene transfer into the brain is associated with significant inflammation and activation of anti-vector and anti-transgene immune responses that curtail the gene delivery of adenoviruses and therapeutic efficacy. Elucidating the molecular mediators of inflammatory and immune responses to adenoviruses injected into the brain should allow us to inhibit their inflammatory actions, thereby reducing vector clearance and enhance adenoviral-mediated gene transfer into the CNS. Cytokines are primary mediators of the immune response and are released during inflammation. Here we report for the first time that injection of replication-deficient adenovirus vectors into the cerebral ventricles of rats causes a rapid increase in body temperature. This fever response precedes any vector-encoded transgene expression and occurs with vectors encoding no transgene, as well as with vectors encoding a therapeutic transgene i.e., HSV1-thymidine kinase. No fever is detected after infection of the striatum, an important brain target in studies on neurodegeneration. After infection of the brain ventricles, CSF levels of immunoreactive tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta increase significantly (up to 300-fold). In the hypothalamus, the locus of thermoregulation in the brain, only IL-1beta and IL-6 are significantly elevated. A neutralizing TNF-alpha antibody has no effect on adenovirus-induced fever. However, pretreatment with either the IL-1 receptor antagonist or the cyclooxygenase inhibitor flurbiprofen completely abolishes adenovirus-induced fever, suggesting that IL-1 and prostaglandins are direct mediators of this response. These results are the first to demonstrate that IL-1, but not TNF-alpha, is the main mediator of a very early inflammatory response to adenovirus in the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952427      PMCID: PMC6786017     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

Authors:  A Lieber; C Y He; L Meuse; D Schowalter; I Kirillova; B Winther; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Role of T cells in inflammation caused by adenovirus vectors in the brain.

Authors:  A P Byrnes; M J Wood; H M Charlton
Journal:  Gene Ther       Date:  1996-07       Impact factor: 5.250

3.  Evidence for the neuronal origin of immunoreactive interleukin-1 beta released by rat hypothalamic explants.

Authors:  G Tringali; C Mancuso; A Mirtella; G Pozzoli; L Parente; P Preziosi; P Navarra
Journal:  Neurosci Lett       Date:  1996-11-29       Impact factor: 3.046

4.  Dopaminergic neurons protected from degeneration by GDNF gene therapy.

Authors:  D L Choi-Lundberg; Q Lin; Y N Chang; Y L Chiang; C M Hay; H Mohajeri; B L Davidson; M C Bohn
Journal:  Science       Date:  1997-02-07       Impact factor: 47.728

5.  Localization of type I interleukin-1 receptor mRNA in the rat brain.

Authors:  K Yabuuchi; M Minami; S Katsumata; M Satoh
Journal:  Brain Res Mol Brain Res       Date:  1994-11

6.  Pulmonary inflammation induced by incomplete or inactivated adenoviral particles.

Authors:  R D McCoy; B L Davidson; B J Roessler; G B Huffnagle; S L Janich; T J Laing; R H Simon
Journal:  Hum Gene Ther       Date:  1995-12       Impact factor: 5.695

7.  Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors.

Authors:  G Bajocchi; S H Feldman; R G Crystal; A Mastrangeli
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

8.  A mechanism for the inhibition of fever by a virus.

Authors:  A Alcamí; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

Authors:  S H Chen; H D Shine; J C Goodman; R G Grossman; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 10.  Fever: role of pyrogens and cryogens.

Authors:  M J Kluger
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

View more
  27 in total

1.  Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types.

Authors:  Clare E Thomas; Penny Edwards; Thomas J Wickham; Maria G Castro; Pedro R Lowenstein
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

4.  Adenoviral-mediated gene transfer into the canine brain in vivo.

Authors:  Marianela Candolfi; Kurt M Kroeger; G Elizabeth Pluhar; Josee Bergeron; Mariana Puntel; James F Curtin; Elizabeth A McNiel; Andrew B Freese; John R Ohlfest; Peter Moore; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

Review 5.  Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.

Authors:  Pedro R Lowenstein; Ronald J Mandel; Wei-Dong Xiong; Kurt Kroeger; Maria G Castro
Journal:  Curr Gene Ther       Date:  2007-10       Impact factor: 4.391

6.  One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.

Authors:  Carlos Barcia; Maximiliano Jimenez-Dalmaroni; Kurt M Kroeger; Mariana Puntel; Alison J Rapaport; Daniel Larocque; Gwendalyn D King; Stephen A Johnson; Chunyan Liu; Weidong Xiong; Marianela Candolfi; Sonali Mondkar; Philip Ng; Donna Palmer; Maria G Castro; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2007-09-25       Impact factor: 11.454

7.  Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Authors:  Franck Lemiale; Wing-pui Kong; Levent M Akyürek; Xu Ling; Yue Huang; Bimal K Chakrabarti; Michael Eckhaus; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

Review 9.  Febrile seizures: mechanisms and relationship to epilepsy.

Authors:  Céline M Dubé; Amy L Brewster; Tallie Z Baram
Journal:  Brain Dev       Date:  2009-02-15       Impact factor: 1.961

10.  Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats.

Authors:  Christelle Sachot; Stephen Poole; Giamal N Luheshi
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.